Teleflex (NYSE: TFX) — Company Overview, News & Financial Data
Teleflex is a global provider of medical technologies focused on critical care and surgical applications to enhance patient care.
Teleflex
Teleflex (NYSE:TFX) is a global provider of medical technologies designed to improve the health and quality of people's lives. This company focuses on products that offer solutions for critical care and surgical applications, aiming to provide clinicians with more effective tools to perform their duties and enhance patient care. Teleflex takes pride in its wide range of products, including respiratory, anesthesia, urology, and cardiac care devices, among others. The firm is committed to innovation, constantly working on developing new products and improving existing ones to meet the evolving needs of the healthcare sector. With operations spread across various countries, Teleflex aims to make a significant impact on global health by offering high-quality medical solutions and actively pursuing growth through strategic acquisitions and partnerships.
Snapshot
Operations
Products and/or services of Teleflex
- Arrow branded catheters and access devices for critical care procedures, ensuring precision and reliability.
- UroLift System for minimally invasive treatment of benign prostatic hyperplasia (BPH), improving patient quality of life.
- The LMA Laryngeal Mask Airway, offering an innovative approach to airway management during anesthesia and emergency care.
- Rusch and Sheridan endotracheal tubes for airway management, catering to a range of clinical needs and settings.
- The Weck brand of surgical instruments and ligation devices, known for quality and efficiency in operating rooms.
- Hudson RCI respiratory products, providing solutions for respiratory care, from emergency services to home health care.
Teleflex executive team
- John R. DerenExecutive VP & CFO
- Daniel V. LogueCorporate VP, General Counsel & Secretary
- Cameron P. HicksCorporate Vice President of Human Resources & Communications
- Jason WeidmanPresident, CEO & Director
- Timothy F. DuffyVP & Chief Information Officer
- Lawrence Soren KeuschVice President of Investor Relations & Strategy Development
- Howard CyrCorporate VP & Chief Compliance Officer
- Matt TomkinVice President of Corporate Development
- James FergusonPresident & GM of Surgical
- Jake NewmanPresident & GM of Vascular and Emergency Medicine
Dividend history
Dividends per share paid by Teleflex, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $1.0200 |
| FY2025 | — | — | — | $1.3600 |
| FY2024 | — | — | — | $1.3600 |
| FY2023 | — | — | — | $1.7000 |
| FY2022 | — | — | — | $1.3600 |
Key financials
Reported results for Teleflex, in USD.
- Market cap
- 5.9B
- Revenue (TTM)
- 2.3B
- P/E ratio
- —
- EPS (diluted, TTM)
- -8.5
- Dividend yield
- 1.0%
- Profit margin
- -45.8%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 2B | 255.8M | -905.6M | |
| 3B | 151M | 69.7M | |
| 3B | 506.3M | 356.3M | |
| 2.8B | 499.7M | 363.1M |